Literature DB >> 8432605

C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

S Albertí1, G Marqués, S Camprubí, S Merino, J M Tomás, F Vivanco, V J Benedí.   

Abstract

The mechanisms of killing of Klebsiella pneumoniae serum-sensitive strains in nonimmune serum by the complement classical pathway have been studied. The bacterial cell surface components that bind C1q more efficiently were identified as two major outer membrane proteins, presumably the porins of this bacterial species. These two outer membrane proteins were isolated from a representative serum-sensitive strain. We have demonstrated that in their purified form, they bind C1q and activate the classical pathway in an antibody-independent manner, with the subsequent consumption of C4 and reduction of the serum total hemolytic activity. Activation of the classical pathway has been observed in human nonimmune serum and agammaglobulinemic serum (both depleted in factor D). Binding of C1q to other components of the bacterial outer membrane, in particular the rough lipopolysaccharide, could not be demonstrated. Activation of the classical pathway by this lipopolysaccharide was also much less efficient than activation by the two outer membrane proteins. The antibody-independent binding of C1q to serum-sensitive strains was independent of the presence of capsular polysaccharide, while strains possessing lipopolysaccharide O antigen bind less C1q and are resistant to complement-mediated killing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432605      PMCID: PMC302811          DOI: 10.1128/iai.61.3.852-860.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier.

Authors:  R E Hancock; H Nikaido
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

2.  C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.

Authors:  W P Kolb; L M Kolb; E R Podack
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

3.  Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.

Authors:  V J Benedí; B Ciurana; J M Tomás
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides.

Authors:  N R Cooper; D C Morrison
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.

Authors:  M Loos; D Bitter-Suermann; M Dierich
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

6.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.

Authors:  T A Gaither; D W Alling; M M Frank
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

9.  Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.

Authors:  C Filip; G Fletcher; J L Wulff; C F Earhart
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

10.  Antibody-independent interaction of the first component of complement with Gram-negative bacteria.

Authors:  M Loos; B Wellek; R Thesen; W Opferkuch
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

View more
  44 in total

1.  Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.

Authors:  D Alvarez; S Merino; J M Tomás; V J Benedí; S Albertí
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Protective efficacy of DNA vaccines encoding outer membrane protein A and OmpK36 of Klebsiella pneumoniae in mice.

Authors:  Prathiba Kurupati; N P Ramachandran; Chit Laa Poh
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

4.  Antibody-independent binding of complement component C1q by Legionella pneumophila.

Authors:  C S Mintz; P I Arnold; W Johnson; D R Schultz
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

5.  Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.

Authors:  S Merino; X Rubires; A Aguilar; S Albertí; S Hernandez-Allés; V J Benedí; J M Tomas
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.

Authors:  Chunfang Gu; Sarah A Jenkins; Qiong Xue; Yi Xu
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

7.  Reptiles as a source of Salmonella O48--clinically important bacteria for children: the relationship between resistance to normal cord serum and outer membrane protein patterns.

Authors:  Gabriela Bugla-Płoskońska; Agnieszka Korzeniowska-Kowal; Katarzyna Guz-Regner
Journal:  Microb Ecol       Date:  2010-05-18       Impact factor: 4.552

8.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

10.  Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Markus M Simon; Reinhard Wallich
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.